AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end, says CEO
Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot
Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot https://ift.tt/2Rg9PuG September 10, 2020 at 09:05AM
Soriot sought to reassure investors after the company and its partner confirmed earlier this week that they had temporarily stopped giving people the experimental shot https://ift.tt/2Rg9PuG September 10, 2020 at 09:05AM
Comments
Post a Comment